What is the recommended management for a pregnant woman diagnosed with cervical cancer, including appropriate staging, treatment options based on tumor stage and gestational age, and considerations for preserving the pregnancy?

Management of Cervical Cancer in Pregnancy

Pregnancy-preserving management should be the initial approach for cervical cancer diagnosed during pregnancy, as pregnancy does not negatively impact maternal prognosis, with treatment strategy determined by tumor stage and gestational age at diagnosis 1.

Diagnostic Approach

Initial evaluation includes:

• Colposcopy with biopsy (safe during pregnancy)
• MRI and/or ultrasonography for staging (avoid CT due to radiation)
• Flat conization if needed for diagnosis
• Clinical examination

Critical caveat: Vaginal bleeding in pregnancy should never be assumed to be pregnancy-related without speculum examination and appropriate cervical cancer screening 2, 3.

Stage-Based Management Algorithm

Stage IA1 Without Lymphovascular Space Invasion

• Cone biopsy is definitive treatment
• Pregnancy can continue to term
• Definitive treatment after delivery

Stage IA1 with LVSI, IA2, and IB1

Before 22 weeks gestation:

• Perform staging pelvic lymphadenectomy first (via laparoscopy before 14-16 weeks or laparotomy after) 1
• If nodes negative: either close follow-up until delivery OR neoadjuvant chemotherapy
• If nodes positive (including micrometastases): recommend termination of pregnancy 1
  • If patient refuses termination: chemotherapy can be considered, but inform patient of possible negative prognostic impact and limited data

After 22 weeks gestation:

• Do NOT perform lymphadenectomy (insufficient nodes retrieved after this point) 1
• Options: delayed treatment with regular follow-up until delivery OR neoadjuvant chemotherapy
• Neoadjuvant chemotherapy can continue until 34-35 weeks gestation

Stage IB2

Before 22 weeks gestation: Two options:

1. Pelvic lymphadenectomy → if negative nodes: chemotherapy or follow-up; if positive nodes: recommend termination
2. Neoadjuvant chemotherapy → surgical staging after tumor downstaging

After 22 weeks gestation:

• Only neoadjuvant chemotherapy is appropriate 1

Stage IB3

• Neoadjuvant chemotherapy is the only pregnancy-preserving option 1
• Staging lymphadenectomy role is controversial
• Follow-up without therapy will compromise prognosis and is NOT recommended 1
• Limited trial data available; further research needed

Stage IIB or Higher, or Any Stage with Positive Lymph Nodes

Pregnancy non-preserving management is indicated:

First trimester:

• Radical hysterectomy with fetus in utero (stages IA2-IB2)
• Chemoradiation with fetus in utero for IB3+ (fetal death occurs within days)

Second trimester:

• Hysterotomy first, then radical hysterectomy (stages IA2-IB2)
• Hysterotomy first, then chemoradiation for IB3+ 1
• Alternative: feticide before chemoradiation for ethical/psychological reasons

Important rationale: Hysterotomy before chemoradiation in second trimester reduces risk of bleeding, cervical rupture, DIC, and psychological trauma 1.

Key Surgical Principles

• Radical trachelectomy during pregnancy has high obstetrical and surgical complication rates and should NOT be recommended 1
• Simple trachelectomy shows low complication rates and is acceptable
• Laparoscopy preferred before 14-16 weeks; laparotomy after this point 1

Delivery Planning

• Cesarean section is standard for delivery 3
• Target delivery at 34-35 weeks if on neoadjuvant chemotherapy 1
• Average gestational age at delivery: 36.3 weeks in recent series 3
• Definitive treatment immediately after delivery

Chemotherapy Timing

• Contraindicated in first trimester 2
• Safe to administer in second and third trimesters
• Platinum-based regimens are standard
• Can continue until 34-35 weeks gestation 1

Prognostic Data

A systematic review of 76 patients with IB1-IB3 tumors managed with staging lymphadenectomy and delayed treatment (mean 16 weeks delay) showed excellent oncological outcomes at median 37.5 months follow-up 1. Recent data confirms disease-free survival in 71% (20/28) of patients at 40-month median follow-up, comparable to non-pregnant populations 3.

Critical Pitfalls to Avoid

1. Never perform lymphadenectomy after 22 weeks - inadequate node retrieval
2. Never delay treatment without surveillance or chemotherapy in IB3 disease - compromises prognosis
3. Never assume vaginal bleeding is pregnancy-related - always examine cervix
4. Never perform radical trachelectomy during pregnancy - excessive complications
5. Never use radiotherapy during pregnancy - absolutely contraindicated 4